Aguiar, Michelle Maria Gonçalves Barão de; Martinez, Renata Miliani 
; Baby, André Rolim ; Serra, Cristina Helena dos Reis
Source: Future Pharmacoly. Unidade: FCF
Subjects: CANDIDÍASE, COVID-19, FORMAS FARMACÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Michelle Maria Gonçalves Barão de et al. Considerations of nystatin roll in oral candidiasis scenario and the COVID-19 pandemic—a review. Future Pharmacoly, v. 3, p. 834–845, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/futurepharmacol3040050. Acesso em: 10 jun. 2024.APA
Aguiar, M. M. G. B. de, Martinez, R. M., Baby, A. R., & Serra, C. H. dos R. (2023). Considerations of nystatin roll in oral candidiasis scenario and the COVID-19 pandemic—a review. Future Pharmacoly, 3, 834–845. doi:10.3390/futurepharmacol3040050NLM
Aguiar MMGB de, Martinez RM, Baby AR, Serra CH dos R. Considerations of nystatin roll in oral candidiasis scenario and the COVID-19 pandemic—a review [Internet]. Future Pharmacoly. 2023 ; 3 834–845.[citado 2024 jun. 10 ] Available from: https://dx.doi.org/10.3390/futurepharmacol3040050Vancouver
Aguiar MMGB de, Martinez RM, Baby AR, Serra CH dos R. Considerations of nystatin roll in oral candidiasis scenario and the COVID-19 pandemic—a review [Internet]. Future Pharmacoly. 2023 ; 3 834–845.[citado 2024 jun. 10 ] Available from: https://dx.doi.org/10.3390/futurepharmacol3040050
